CLINICAL-EXPERIENCE WITH MONOCLATE, A MONOCLONAL-ANTIBODY PURIFIED FACTOR-VIII PREPARATION FROM HUMAN PLASMA

被引：0

作者：

SCHREIBER, AB

PETILLO, JJ

LAMON, KD

机构：

来源：

BIOTECHNOLOGY IN BLOOD TRANSFUSION | 1988年 / 21卷

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

收藏

页码：231 / 237

页数：7

相关论文

共 50 条

[31] STUDIES ON A MONOCLONAL-ANTIBODY TO HUMAN FACTOR-VIII COAGULANT ACTIVITY, WITH A DESCRIPTION OF A FACILE 2-SITE FACTOR-VIII COAGULANT ANTIGEN-ASSAY
BROWN, JE
THUY, LP
CARTON, CL
HOUGIE, C
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1983, 101 (05): : 793 - 805
[32] Elimination of non-lipid enveloped viruses in the preparation of a monoclonal antibody purified and pasteurized factor VIII concentrate (Monoclate-P(R)).
Chandra, S
Cavanaugh, J
Barham, R
Feldman, F
BLOOD, 1995, 86 (10) : 768 - 768
[33] FACTOR-VIII POLYPEPTIDE ANALYSIS OF RECOMBINANT AND MONOCLONAL ANTIBODY-PURIFIED FVIII CONCENTRATES
KEMBALLCOOK, G
BEVAN, SA
THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 198 - 198
[34] APPARENT MOLECULAR-WEIGHT OF PURIFIED HUMAN FACTOR-VIII PROCOAGULANT PROTEIN COMPARED WITH PURIFIED AND PLASMA FACTOR-VIII PROCOAGULANT PROTEIN ANTIGEN
WEINSTEIN, MJ
FULCHER, CA
CHUTE, LE
ZIMMERMAN, TS
BLOOD, 1983, 62 (05) : 1114 - 1117
[35] A FACTOR-VIII NEUTRALIZING MONOCLONAL-ANTIBODY AND A HUMAN INHIBITOR ALLOANTIBODY RECOGNIZING EPITOPES IN THE C2 DOMAIN INHIBIT FACTOR-VIII BINDING TO VONWILLEBRAND-FACTOR AND TO PHOSPHATIDYLSERINE
SHIMA, M
SCANDELLA, D
YOSHIOKA, A
NAKAI, H
TANAKA, I
KAMISUE, S
TERADA, S
FUKUI, H
THROMBOSIS AND HAEMOSTASIS, 1993, 69 (03) : 240 - 246
[36] OUTCOME ANALYSIS MODEL FOR CONTINUOUS-INFUSION OF MONOCLONAL ANTIBODY-PURIFIED FACTOR-VIII IN HEMOPHILIA-A PATIENTS WITH FACTOR-VIII INHIBITORS
GORDON, EM
CHAN, L
GOLDSMITH, JC
THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1024 - 1024
[37] FACTOR-VIII-C INHIBITOR ASSOCIATED WITH MONOCLONAL-ANTIBODY PURIFIED FVIII CONCENTRATE
KESSLER, CM
SACHSE, K
LANCET, 1990, 335 (8702) : 1403 - 1403
[38] ELISA FOR FACTOR-VIII ANTIGEN CARRIED OUT WITH POLYCLONAL HUMAN MODERATE TITER INHIBITOR AND COMMERCIAL MONOCLONAL-ANTIBODY
JORQUERA, JI
MONTORO, JM
AZNAR, JA
CASANA, P
LLOPIS, F
THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 212 - 212
[39] CLINICAL-EXPERIENCE OF A NEW MONOCLONAL-ANTIBODY PURIFIED FACTOR-IX - HALF-LIFE, RECOVERY, AND SAFETY IN PATIENTS WITH HEMOPHILIA-B
KIM, HC
MCMILLAN, CW
WHITE, GC
BERGMAN, GE
SAIDI, P
SEMINARS IN HEMATOLOGY, 1990, 27 (02) : 30 - 36
[40] A MONOCLONAL ANTIBODY-DEPLETED FACTOR VIII-DEFICIENT PLASMA SUITABLE FOR USE IN FACTOR-VIII ASSAYS
TUDDENHAM, EGD
ROTBLAT, F
TAKASE, T
KERNOFF, PBA
MIDDLETON, S
CHAND, S
GOODALL, AH
RICERCA IN CLINICA E IN LABORATORIO, 1986, 16 (01): : 131 - 131

← 1 2 3 4 5 →